Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Triple Negative Breast Neoplasms × atezolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 17 OTHER 16 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 2 olaparib 1 fludarabine 1 durvalumab 1 atezolizumab 1 Methotrexate 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03281954 2024-04-08

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

NSABP Foundation Inc

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡